Nitric oxide and multiple sclerosis
Purchase on Springer.com
$39.95 / €34.95 / £29.95*
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.
Nitric oxide (NO) is a free radical signaling molecule with remarkably complex biochemistry. Its involvement in multiple sclerosis (MS) had been postulated soon after the discovery of the critical role NO plays in inflammation. However, the extent of NO’s contribution to MS is not yet understood, party due to the often opposing roles that NO can play in cellular processes. This review briefly covers new developments in the area of NO that may be relevant to MS. It also describes recent progress in understanding the role of NO in MS, new potential targets of the action of NO in the cell, and prospects for NO-based therapies.
- Smith KJ, Lassmann H: The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002, 1:232–241. This is a detailed review of the contribution of NO to MS and EAE and of potential NO-based therapies. CrossRef
- Parkinson JF, Mitrovic B, Merrill JE: The role of nitric oxide in multiple sclerosis. J Mol Med 1997, 75:174–186. CrossRef
- Smith KJ, Kapoor R, Felts PA: Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999, 9:69–92. CrossRef
- Willenborg DO, Staykova MA, Cowden WB: Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis: a review. J Neuroimmunol 1999, 100:21–35. CrossRef
- Bredt DS: Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999, 31:577–596. CrossRef
- Ignarro LJ: Nitric Oxide: Biology and Pathobiology, edn 1. San Diego: Academic Press; 2000.
- Nathan C: Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest 2003, 111:769–778. CrossRef
- Alderton WK, Cooper CE, Knowles RG: Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357:593–615. CrossRef
- Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 1997, 100:2417–2423. CrossRef
- Ridnour LA, Thomas DD, Mancardi D, et al.: The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol Chem 2004, 385:1–10. CrossRef
- Fang FC: Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat Rev Microbiol 2004, 2:820–832. CrossRef
- Hess DT, Matsumoto A, Kim SO, et al.: Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 2005, 6:150–166. CrossRef
- Chung KK, Thomas B, Li X, et al.: S-nitrosylation of parkin regulates ubiquitination and compromises parkin’s protective function. Science 2004, 304:1328–1331. CrossRef
- Yao D, Gu Z, Nakamura T, et al.: Nitrosative stress linked to sporadic Parkinson’s disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity. Proc Natl Acad Sci U S A 2004, 101:10810–10814. CrossRef
- Bryan NS, Rassaf T, Maloney RE, et al.: Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci U S A 2004, 101:4308–4313. This article documents the presence of large amounts of RNNO compounds in tissues. CrossRef
- Janero DR, Bryan NS, Saijo F, et al.: Differential nitros(yl)ation of blood and tissue constituents during glyceryl trinitrate biotransformation in vivo. Proc Natl Acad Sci U S A 2004, 101:16958–16963. CrossRef
- Baker PR, Schopfer FJ, Sweeney S, Freeman BA: Red cell membrane and plasma linoleic acid nitration products: synthesis, clinical identification, and quantitation. Proc Natl Acad Sci U S A 2004, 101:11577–11582. This paper describes endogenous nitroderivatives of fatty acids with anti-inflammatory activity. CrossRef
- Liu X, Miller MJ, Joshi MS, et al.: Accelerated reaction of nitric oxide with O2 within the hydrophobic interior of biological membranes. Proc Natl Acad Sci U S A 1998, 95:2175–2179. CrossRef
- Schopfer FJ, Lin Y, Baker PR, et al.: Nitrolinoleic acid: an endogenous peroxisome proliferator-activated receptor (gamma) ligand. Proc Natl Acad Sci U S A 2005, 102:2340–2345. CrossRef
- Lundberg JO, Weitzberg E, Cole JA, Benjamin N: Nitrate, bacteria and human health. Nat Rev Microbiol 2004, 2:593–602. This is a detailed review of NOS-independent generation of nitrogen oxides. CrossRef
- Blanco Y, Yague J, Graus F, Saiz A: No association of inducible nitric oxide synthase gene (NOS2A) to multiple sclerosis. J Neurol 2003, 250:598–600. CrossRef
- Tajouri L, Martin V, Ovcaric M, et al.: Investigation of an inducible nitric oxide synthase gene (NOS2A) polymorphism in a multiple sclerosis population. Brain Res Bull 2004, 64:9–13. CrossRef
- Tajouri L, Ferreira L, Ovcaric M, et al.: Investigation of a neuronal nitric oxide synthase gene (NOS1) polymorphism in a multiple sclerosis population. J Neurol Sci 2004, 218:25–28. CrossRef
- Barcellos LF, Begovich AB, Reynolds RL, et al.: Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis. Ann Neurol 2004, 55:793–800. CrossRef
- Kanwar JR, Kanwar RK, Krissansen GW: Simultaneous neuroprotection and blockade of inflammation reverses autoimmune encephalomyelitis. Brain 2004, 127:1313–1331. This article demonstrates that a combination of three drugs can reverse EAE. It also shows a concomitant decrease in NOS activity. CrossRef
- Broholm H, Andersen B, Wanscher B, et al.: Nitric oxide synthase expression and enzymatic activity in multiple sclerosis. Acta Neurol Scand 2004, 109:261–269. CrossRef
- Hill KE, Zollinger LV, Watt HE, et al.: Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage. J Neuroimmunol 2004, 151:171–179. CrossRef
- Acar G, Idiman F, Idiman E, et al.: Nitric oxide as an activity marker in multiple sclerosis. J Neurol 2003, 250:588–592. CrossRef
- Danilov AI, Andersson M, Bavand N, et al.: Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 2003, 136:112–118. CrossRef
- Rejdak K, Eikelenboom MJ, Petzold A, et al.: CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 2004, 63:1439–1445.
- Garthwaite G, Goodwin DA, Batchelor AM, et al.: Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 2002, 109:145–155. CrossRef
- Hooper DC, Bagasra O, Marini JC, et al.: Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci U S A 1997, 94:2528–2533. CrossRef
- Cross AH, Manning PT, Keeling RM, et al.: Peroxynitrite formation within the central nervous system in active multiple sclerosis. J Neuroimmunol 1998, 88:45–56. CrossRef
- Liu JS, Zhao ML, Brosnan CF, Lee SC: Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol 2001, 158:2057–2066.
- Kahl KG, Schmidt HH, Jung S, et al.: Experimental autoimmune encephalomyelitis in mice with a targeted deletion of the inducible nitric oxide synthase gene: increased T-helper 1 response. Neurosci Lett 2004, 358:58–62. CrossRef
- Touil T, Deloire-Grassin MS, Vital C, et al.: In vivo damage of CNS myelin and axons induced by peroxynitrite. Neuroreport 2001, 12:3637–3644. CrossRef
- Scott GS, Spitsin SV, Kean RB, et al.: Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci U S A 2002, 99:16303–16308. CrossRef
- Scott GS, Virag L, Szabo C, Hooper DC: Peroxynitrite-induced oligodendrocyte toxicity is not dependent on poly(ADP-ribose) polymerase activation. Glia 2003, 41:105–116. CrossRef
- Takao T, Flint N, Lee L, et al.: 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem 2004, 89:660–673. CrossRef
- Bizzozero OA, DeJesus G, Howard TA: Exposure of rat optic nerves to nitric oxide causes protein S-nitrosation and myelin decompaction. Neurochem Res 2004, 29:1675–1685. This article describes NO-induced defects to myelin and selective S-nitrosylation of PLP by NO. CrossRef
- Calabrese V, Scapagnini G, Ravagna A, et al.: Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res 2002, 70:580–587. CrossRef
- Boullerne AI, Rodriguez JJ, Touil T, et al.: Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J Neurosci 2002, 22:123–132. This article proposes S-nitrosylation as a novel marker for disease progression in MS.
- Boullerne AI, Petry KG, Meynard M, Geffard M: Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J Neuroimmunol 1995, 60:117–124. CrossRef
- McDonald JW, Althomsons SP, Hyrc KL, et al.: Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998, 4:291–297. CrossRef
- Pitt D, Werner P, Raine CS: Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 2000, 6:67–70. CrossRef
- Rosin C, Bates TE, Skaper SD: Excitatory amino acid induced oligodendrocyte cell death in vitro: receptor-dependent and -independent mechanisms. J Neurochem 2004, 90:1173–1185. CrossRef
- Pitt D, Nagelmeier IE, Wilson HC, Raine CS: Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis. Neurology 2003, 61:1113–1120.
- Mander P, Borutaite V, Moncada S, Brown GC: Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J Neurosci Res 2005, 79:208–215. This article shows that NO-induced cell death increases 10-fold under hypoxia. CrossRef
- Lassmann H: Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 2003, 206:187–191. CrossRef
- Aboul-Enein F, Lassmann H: Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol (Berl) 2005, 109:49–55. CrossRef
- Bossy-Wetzel E, Talantova MV, Lee WD, et al.: Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron 2004, 41:351–365. This article describes a molecular mechanism of NO/zinc-mediated cell death. CrossRef
- Kahl KG, Zielasek J, Uttenthal LO, et al.: Protective role of the cytokine-inducible isoform of nitric oxide synthase induction and nitrosative stress in experimental autoimmune encephalomyelitis of the DA rat. J Neurosci Res 2003, 73:198–205. This article shows a protective role of iNOS in EAE and discusses often contradictory results on the benefits of blocking NO production for EAE and MS. CrossRef
- Staykova MA, Paridaen JT, Cowden WB, Willenborg DO: Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am J Pathol 2005, 166:147–157.
- Okuda Y, Sakoda S, Fujimura H, Yanagihara T: Aminoguanidine, a selective inhibitor of the inducible nitric oxide synthase, has different effects on experimental allergic encephalomyelitis in the induction and progression phase. J Neuroimmunol 1998, 81:201–210. CrossRef
- O’Brien NC, Charlton B, Cowden WB, Willenborg DO: Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease. J Immunol 2001, 167:5904–5912.
- Xu LY, Yang JS, Link H, Xiao BG: SIN-1, a nitric oxide donor, ameliorates experimental allergic encephalomyelitis in Lewis rats in the incipient phase: the importance of the time window. J Immunol 2001, 166:5810–5816.
- Imitola J, Snyder EY, Khoury SJ: Genetic programs and responses of neural stem/progenitor cells during demyelination: potential insights into repair mechanisms in multiple sclerosis. Physiol Genomics 2003, 14:171–197. This is a detailed review of the prospects and limitations of stem cell-based therapies for MS.
- Packer MA, Stasiv Y, Benraiss A, et al.: Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci U S A 2003, 100:9566–9571. CrossRef
- Park C, Sohn Y, Shin KS, et al.: The chronic inhibition of nitric oxide synthase enhances cell proliferation in the adult rat hippocampus. Neurosci Lett 2003, 339:9–12. CrossRef
- Cheng A, Wang S, Cai J, et al.: Nitric oxide acts in a positive feedback loop with BDNF to regulate neural progenitor cell proliferation and differentiation in the mammalian brain. Dev Biol 2003, 258:319–333. CrossRef
- Moreno-Lopez B, Romero-Grimaldi C, Noval JA, et al.: Nitric oxide is a physiological inhibitor of neurogenesis in the adult mouse subventricular zone and olfactory bulb. J Neurosci 2004, 24:85–95. CrossRef
- Nitric oxide and multiple sclerosis
Current Neurology and Neuroscience Reports
Volume 5, Issue 3 , pp 232-238
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links